Notes to the Accounts (continued)


29. Funding committee members receiving grants (continued) Of the scientists above, those who headed projects that received grant awards in excess of £1 million in the year are:


£000


Paterson Institute for Cancer Research Nic Jones University of Oxford


Imperial College London


Queen Mary, University of London Imperial College London


The Institute of Cancer Research University of Edinburgh


The University of Birmingham The Institute of Cancer Research University of Cambridge


Gillies William McKenna


Raoul Charles Dalmedo Coombes Kairbaan Hodivala-Dilke Eric O Aboagye Martin O Leach


Malcolm G Dunlop Philip J Johnson David Barford Jonathon Pines


11,712 3,987 2,390 1,954 1,815 1,784 1,524 1,368 1,352 1,077


Scientists who serve on the Group’s grant-making committees may not participate in any decisions that relate to funding either of research projects where they have an interest or of their institutions.


Professor Peter Johnson, Chief Clinician, is a member of both the Charity’s Executive and Scientific Executive Boards.


Professor Nic Jones, Chief Scientist, is a member of both the Charity’s Executive and Scientific Executive Boards and is also a fellow of the Gibb Research Fellowship Endowment Fund.


30. Pensions Cancer Research UK operates a defined benefit pension scheme and defined contribution pension schemes. The defined benefit pension scheme closed to new members on 31 December 2009.


a) Pension scheme accounted for as a defined benefit scheme The contributions paid to the Cancer Research UK Pension Scheme are in accordance with the rates agreed following the 31 March 2009 actuarial valuation.


In relation to all members and new entrants, the Group has contributed, as a percentage of members’ salaries, at the following rates:


To 30 April 2010


1 May 2010 to 31 December 2010 From 1 January 2011


Rate contributed 20.1%


19.1% 19.1% - 26.1%


In addition the Group contributed 2.4% of salaries for ‘Stakeholder members’ and 0.2% of salaries for members covered for lump sum death in service benefits only.


The Group expects to pay contributions of £20.0 million for the year to 31 March 2012 (contributions actually paid in the year to 31 March 2011 were £17.6 million).


As required by FRS17, the defined benefit liabilities have been measured using the projected unit method. The tables over the page state the FRS17 actuarial assumptions upon which the valuation of the scheme was based.


54 / Annual Report and Accounts / Notes to the Accounts


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64